Translating Pharmacokinetics and Pharmacodynamics into Clinical Decision-Making: A Practical Guide to the Use of Risperidone ISM<sup>®</sup> in Schizophrenia. [PDF]
Solmi M +6 more
europepmc +1 more source
Trends in drug-induced deaths in Australia, 1997-2018 [PDF]
Degenhardt, Louisa ; https://orcid.org/ +9 more
core +1 more source
Risperidone-Induced Nasal Congestion and Increased Urinary Frequency. [PDF]
Abu Baker H, Alnuaimi B, Alkot A.
europepmc +1 more source
Lansoprazole as a possible trigger of restless legs syndrome with suspected periodic limb movement disorder in a hemodialysis patient: a case report. [PDF]
Nakata H, Nishiwaki K.
europepmc +1 more source
Prevalence and associated factors of antipsychotic-induced extrapyramidal symptoms in the Tigray region. [PDF]
Gebremariam EH +7 more
europepmc +1 more source
Aripiprazole- and Lurasidone-Induced Akathisia: A Case Report and Literature Review. [PDF]
Kandra K.
europepmc +1 more source
Deutetrabenazine in Hyperkinetic Movement Disorders: VMAT2 Modulation From Choreiform Disorders to Hyperkinetic Dystonic Syndromes. [PDF]
Fang Y, Lu Y, Zhu S, Huang S.
europepmc +1 more source
Marked Improvement of Chronic Motor and Phonic Tics With Cariprazine in an Adult With Tourette Syndrome With Comorbid Bipolar Disorder: A Case Report. [PDF]
Feinberg GL +3 more
europepmc +1 more source
Substantia nigra-related gene polymorphisms associated with acute antipsychotic-induced movement disorders. [PDF]
Hashimoto K.
europepmc +1 more source
Mechanism-Based Polypharmacy as a Repurposing Strategy: The Case of D-Cycloserine and Lurasidone. [PDF]
Franzen AD +3 more
europepmc +1 more source

